Market Tracker

12/09 5:16pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.69
Delayed Data
As of Dec 09
 +0.06 / +1.65%
Today’s Change
1.61
Today|||52-Week Range
5.44
+20.20%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.63
Today’s open3.67
Day’s range3.64 - 3.84
Volume1,861,501
Average volume (3 months)1,668,000
Market cap$384.6M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+28.23%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.01+0.27%
LNTHLantheus Holdings In...+0.15+1.61%
OXFDOxford Immunotec Glo...+0.27+1.84%
VCYTVeracyte Inc-0.09-1.19%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts